Safety of mRNA vaccines administered during the initial 6 months of the US COVID-19 vaccination programme: an observational study of reports to the Vaccine Adverse Event Reporting System and v-safeHannah G. Rosenblum, David K. Shay, Bicheng Zhang et al.|The Lancet Infectious Diseases|2022Cited by 183
Safety Monitoring of mRNA Vaccines Administered During the Initial 6 Months of the U.S. COVID-19 Vaccination Program: Reports to Vaccine Adverse Events Reporting System (VAERS) and v-safeHannah G. Rosenblum, David K. Shay, Julianne Gee et al.|medRxiv|2021Cited by 1